Prominent V-Waves Augment Right Ventricular Afterload Independent of the Lung Vessels in Heart Failure: Implications for Clinical Assessment of Pulmonary Vascular Disease
Abstract
Background: Left atrial (LA) stiffening augments the LA V-wave, pressurizing the pulmonary artery (PA) out of proportion to left ventricular end-diastolic pressure. We characterized the pathophysiologic, diagnostic, and clinical implications of LA stiffening, as defined by prominent V-waves, in HFpEF. Methods: In this retrospective cohort study, patients with HFpEF and less than moderate mitral regurgitation at rest underwent invasive hemodynamic exercise testing. Patients with heightened operant LA stiffening were defined by PA wedge pressure (PAWP) V-wave exceeding mean PAWP by ≥10 mmHg. A previously-used formula for V-wave-corrected PAWP was validated against the PAWP-waveform pressure-time-area to explore impact of the V-wave on transpulmonary pressure gradients (TPG). Clinical, echocardiographic, hemodynamic, and outcome data were compared in patients with and without prominent V-waves. Results: Compared with patients without prominent V-waves (n=844, 79%), those with prominent V-waves (n=225, 21%) were older and more likely to be women, with more severe LA myopathy, evidenced by greater LA volume index (42.2±15.0 vs. 32.5±13.0 mL/m2; P<0.001), lower LA reservoir strain (16.4±7.5 vs 23.2±8.3%; P<0.001), more atrial fibrillation (61.3% vs. 22.9%; P<0.001), and increased operant LA reservoir stiffness (0.59±0.25 vs 0.23±0.24 mmHg/mL; P<0.001). Patients with prominent V-waves had markedly higher PA systolic pressure than those without (54±16 vs. 38±12 mmHg; P<0.001) despite no difference in end-diastolic PAWP-PA pressure gradient (3±5 vs. 3±4 mmHg; P=0.950). Incorporating the V-wave into PAWP improved correlation between directly measured PAWP pressure-time-integral compared with mid-A wave PAWP (R2=0.96 vs R2=0.86, P<0.001 for comparison). In patients with prominent V-waves, the prevalence of combined pre- and post-capillary pulmonary hypertension decreased from 60.2% to 29.3% after V-wave correction for TPG. Despite similar corrected pulmonary vascular resistances in patients with and without prominent V-waves, apparent PA compliance was much lower in patients with prominent V-waves (3.03±1.56 vs. 4.90±2.27 mL/mmHg; P<0.001), augmenting right ventricular (RV) afterload, and these changes were coupled with more severe RV dysfunction, tricuspid regurgitation, blunted cardiopulmonary exercise reserve, and increased risk of HF hospitalization or death in patients with vs without prominent V-waves (adjusted HR: 2.09; 95% CI: 1.53–2.86; P<0.001). Conclusions: Over 1 in 5 patients with HFpEF display prominent V-waves in excess of end-diastolic PAWP. This augments RV afterload due to backward transmission of the V-wave, contributing to right heart failure that is independent of the pulmonary vasculature. Failure to account for the V-wave in hemodynamic assessment overestimates the severity of pulmonary vascular disease present.